Latest News about MRK
Recent news which mentions MRK
2 Dividend Stocks Billionaires Are Buying: Should You?
June 07, 2024
From Motley Fool
From InvestorPlace
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
June 04, 2024
From Benzinga
Comparative Study: Merck & Co And Industry Competitors In Pharmaceuticals Industry
June 04, 2024
From Benzinga
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma Patients
June 03, 2024
From Benzinga
From Benzinga
From InvestorPlace
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence
May 29, 2024
From Benzinga
From Benzinga
From Benzinga
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
May 27, 2024
From Benzinga
From Benzinga
From Motley Fool
From InvestorPlace
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma Treatment
May 13, 2024
From Benzinga
From Benzinga
From InvestorPlace
From InvestorPlace
Tags
PFE
NVO
NYSE:LLY,NYSE:NVO,NASDAQ:AMGN,NYSE:PFE,NASDAQ:VKTX,NASDAQ:GPCR,NASDAQ:ALT,NASDAQ:AZN,NYSE:MRK
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.